LEOSS: Lean European Open Survey on SARS-CoV-2 Infected Patients Duration of neurological comorbidity Pre-existing neurological medication Neurological status Neurological status prior to current illness: History of Gait Neurological status prior to current illness: History of falls Neurological status prior to current illness: Cognitive status Neurological status prior to current illness: Speech Neurological status prior to current illness: Swallowing Neurological status prior to current illness: Respiration Previous nursing need Specification of the indicated other neurological comorbidities Specification of indicated cerebrovascular disease Hemorrhagic stroke: Pattern of bleeding Ischemic stroke: Most likely cause of stroke (TOAST) Modified rankin scale at admission Atrial fibrillation Internal carotid artery stenosis > 50 % Cerebrovascular disease: Medication Multiple Sclerosis subtype & severity Multiple Sclerosis subtype Severity of Multiple Sclerosis at Baseline B-cells at Baseline Multiple Sclerosis: Immunomodulatory medication at Baseline MS: Adjustments of immunomodulatory therapy in the context of COVID-19 Discontinued immunomodulatory therapy Multiple Sclerosis: Relapse treatment in the last three months Multiple Sclerosis: Relapse treatment in the last three months Neurodegeneration Indicate type of Dementia Indicate type of movement disorder Indicate Motoneuron Disease Cognitive / neuropsychiatric impairment during the course of COVID-19 Memory deficit: Indicate the phase of occurrence Apraxia: Indicate the phase of occurrence Neglect: Indicate the phase of occurrence Impaired orientation: Indicate the phase of occurrence Other cognitive/neuropsychiatric impairment Visual impairment during the course of COVID-19 Impaired visual field: Indicate the phase of occurrence Impaired visual acuity: Indicate phase of occurrence Oculomotoric impairment during the course of COVID-19 Double vision / Palsy of gaze: Indicate the phase of occurrence Cranial nerve III (N. oculomotorius): Indicate phase of occurrence Cranial nerve IV (N. trochlearis): Indicate phase of occurrence Cranial nerve VI (N. abducens): Indicate phase of occurrence Supranuclear gaze palsy (e.g. internuclear ophthalmopglegia): Indicate phase of occurrence Nystagmus: Indicate phase of occurrence Other oculomotoric impairment: Indicate phase of occurrence Paresis during the course of COVID-19 Paresis left arm: Indicate phase of occurrence Paresis right arm: Indicate phase of occurrence Paresis left leg: Indicate phase of occurrence Paresis right leg: Indicate phase of occurrence Other paresis: Please indicate phase of occurrence Abnormal muscle reflexes during the course of COVID-19 Depressed muscle reflexes: Please indicate the phase of occurrence Increased muscle reflexes: Please indicate the phase of occurrence Sensory deficit during the course of COVID-19 Focal sensory deficit: Please indicate the phase of occurrence Peripheral symmetric sensory deficit: Please indicate the phase of occurrence Other sensory deficit: Please indicate the phase of occurrence Other neurological findings during the course of COVID-19 Aphasia: Please indicate the phase of occurrence Dysarthria: Indicate the phase of occurrence Facial Palsy: Indicate the phase of occurrence Swallowing impaired: Indicate the phase of occurrence Vertigo: Indicate the phase of occurrence Neuralgia: Indicate the phase of occurrence Positive pyramidal signs (e.g. Babinski): Please indicate the phase of occurrence Ataxia: Indicate the phase of occurrence Unsteady gait: Indicate the phase of occurrence Neurological diagnostics: cCT & cMRI cCT in Uncomplicated phase cCT in Complicated phase cCT in Critical phase cMRI in Uncomplicated phase cMRI in Complicated phase cMRI in Critical phase Neurological diagnostics: EEG EEG in Uncomplicated phase EEG in Complicated phase EEG in Critical phase Neurological diagnostics: Electrophysiology Electrophysiology in Uncomplicated phase Electrophysiology in Complicated phase Electrophysiology in Critical phase Neurological diagnostics: Spinal tap - cerebrospinal fluid Cell count in Uncomplicated phase Cell count in Complicated phase Cell count in Critical phase Glucose concentration in Uncomplicated phase Glucose concentration in Complicated phase Glucose concentration in Critical phase Lactate concentration in Uncomplicated phase Lactate concentration in Complicated phase Lactate concentration in Critical phase Protein concentration in Uncomplicated phase Protein concentration in Complicated phase Protein concentration in Critical phase Oligoclonal bands type in Uncomplicated phase Oligoclonal bands type in Complicated phase Oligoclonal bands type in Critical phase Neurological diagnostics: Spinal tap - pathogens Bacteria Fungi Virus Antineuronal Antibody Status Indicate the phase in which the above indicated pathogen and antibody testing status was performed Is data entry for this section finished? Is data entry for this section finished? 
